Literature DB >> 5105002

Australia antigen: large-scale purification from human serum and biochemical studies of its proteins.

J L Gerin, P V Holland, R H Purcell.   

Abstract

Biophysical techniques are described for the large-scale isolation of Australia antigen (Au) from unit quantities of human serum by using the batch-type zonal centrifuge rotors. A three-step procedure involving isopycnic banding of the particle in CsCl density gradients and rate-zonal centrifugation on sucrose gradients resulted in a highly purified Au preparation which was used for biochemical studies of Au proteins and as immunizing antigen for the production of reagent antiserum in animals. The spherical form of Au, which was devoid of detectable nucleic acid, was composed of two major proteins (AuP1 and AuP2) and a minor protein (AuP3) of 26,000, 32,000, and 40,000 molecular weight, respectively, as determined by acrylamide gel electrophoresis. The significance of these findings to the possibility of Au subtypes is discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5105002      PMCID: PMC356164     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

2.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

3.  A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis.

Authors:  A Chrambach; R A Reisfeld; M Wyckoff; J Zaccari
Journal:  Anal Biochem       Date:  1967-07       Impact factor: 3.365

4.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

5.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

6.  Hepatitis antigen. Correlation with disease and infectivity of blood-donors.

Authors:  D J Gocke; N B Kavey
Journal:  Lancet       Date:  1969-05-31       Impact factor: 79.321

7.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

8.  Observations on Australia antigen in Japanese.

Authors:  K Okochi; S Murakami
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

9.  Preparation and recovery of cesium compounds for density gradient solutions.

Authors:  R R Wright; W S Pappas; J A Carter; C W Weber
Journal:  Natl Cancer Inst Monogr       Date:  1966-06

10.  Digital computation of sedimentation coefficients in zonal centrifuges.

Authors:  B S Bishop
Journal:  Natl Cancer Inst Monogr       Date:  1966-06
View more
  43 in total

1.  Expression of hepatitis B surface antigen in transgenic plants.

Authors:  H S Mason; D M Lam; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

2.  N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen.

Authors:  Y Sugimoto; S Toyoshima
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

3.  Demonstration of subpopulations of Dane particles.

Authors:  P M Kaplan; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

4.  Large-scale purification of hepatitis B surface antigen.

Authors:  J Vnek; A M Prince
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

5.  Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue.

Authors:  A Trevisan; G Realdi; C Losi; V Ninfo; M Rugge; L Rampinelli
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

6.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

7.  Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

Authors:  R Chairez; F B Hollinger; J P Brunschwig; G R Dreesman
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

8.  Two distinct types of hepatitis in experimental hepatitis B virus infection.

Authors:  T Shikata; T Karasawa; K Abe
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

9.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Proteins of hepatitis B surface antigen.

Authors:  J W Shih; J L Gerin
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.